An interdisciplinary research team from Leipzig University and the Saxon AI center ScaDS.AI has developed a novel approach ...

Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.

Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 billion of non-cash charges related to manufacturing resizing ...

The development of bacterial vaccines has played a critical role in combating infectious diseases, significantly reducing mortality and morbidity worldwide.

Robert F. Kennedy Jr. cited a disputed study from a close network of fellow vaccine skeptics during his confirmation hearings ...

Boehringer will leverage ExpressionEdits' Genetic Syntax Engine which generates optimized introns to increase protein expression.

Terrain Biosciences launches from stealth today as the world's first RNA design-build company, using advanced AI and its ...

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...

Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually.

Responding to the challenges posed by the rise of new epizootics, this new technological platform will enable Ceva to develop effective, industrialized, and competitive vaccine solutions capable of ...